BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30
• 31

• Drug Development

  Prothena Receives FDA Fast Track Designation For NEOD001, A Monoclonal Antibody For The Treatment Of Patients With AL Amyloidosis

  December 15, 2014

   · 

  6 min read
• Pharm Country

  FDA Clears Olympus Corporation’ Narrow Band Imaging (NBI) For Effective Targeting Of Bladder Cancer Biopsies And Improved Visualization Of Tumor Margins

  December 15, 2014

   · 

  8 min read
• Policy

  Amway Release: eSpring Brand Is First To Be Certified To All 15 New NSF/ANSI 401 Emerging Contaminants

  December 15, 2014

   · 

  4 min read
• Business

  Biomet Inc. Announces Fiscal Year 2015 Second Quarter Conference Call

  December 15, 2014

   · 

  1 min read
• Biotech Bay

  BioTime Subsidiary OncoCyte Corporation Completes Initial Enrollment Of Clinical Study Of Urine-Based Bladder Cancer Diagnostic

  December 15, 2014

   · 

  9 min read
• Genomic Health, Inc.: New Oncotype DX® Data Presented At 2014 San Antonio Breast Cancer Symposium Further Demonstrate The Practice-Changing Impact Of The Test In Guiding The Treatment Of Early Stage Breast Cancer

  December 15, 2014

   · 

  5 min read
• Business

  Ignyta Announces Amendment To License Agreement With Nerviano Medical Sciences (NervianoMS)

  December 15, 2014

   · 

  1 min read
• Job Trends

  JunoPacific Expands; Will Boost Workforce 25 To 50% Over The Next Two Years

  December 15, 2014

   · 

  2 min read
• Drug Development

  VBL Therapeutics Announces Last Patient Out In Phase 2 Clinical Studies Of VB-201 In Psoriasis And Ulcerative Colitis

  December 15, 2014

   · 

  5 min read
• Policy

  Genentech Submits New Drug Application To FDA For Investigational Cobimetinib Used In Combination With Zelboraf (Vemurafenib) In Advanced Melanoma

  December 15, 2014

   · 

  8 min read